当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2018年第10期
编号:13274980
盐酸羟考酮缓释片联合即释吗啡片滴定癌痛的疗效及不良反应分析
http://www.100md.com 2018年10月1日 《健康必读·下旬刊》 2018年第10期
     【摘 要】:目的 分析盐酸羟考酮联合吗啡对癌痛的控制作用和安全性。方法 选取我院自2016年1月-2018年1月就诊的癌痛患者71例,采用即释吗啡片联合盐酸羟考酮缓释片的镇痛方案。分析用药后各时间段的疼痛和不良反应。结果 用药后1d患者的疼痛缓解率为70.42%,3d为77.46%,7d为92.96%。不良反应中便秘为52.11%、头晕14.08%。结论 应用盐酸羟考酮缓释片和吗啡可有效地控制癌痛,耐受不良反应。

    【关键词】:盐酸羟考酮;安全性;癌痛

    Efficacy and side effects of Oxycodone Hydrochloride Prolonged-release Tablets with morphine on cancer pain

    Abstract Objective To analyze effect and safety of oxycodone hydrochloride with morphine on cancer pain. Methods 71 cases by cancer pain from January 2016 to January 2018 were randomly selected. Immediate-release morphine and oxycodone hydrochloride sustained-release tablets was adopted. Pain and adverse reactions in different periods were analyzed. Results Pain relief rate in 1d was 70.42% ......

您现在查看是摘要页,全文长 3875 字符